Effects of gustatory stimulants of salivary secretion on salivary pH and flow in patients with Sjögren's syndrome: A randomized controlled trial

Journal of Oral Pathology and Medicine

Volumn 40, Issue 10, 2011, Pages 785-792

  Da Silva Marques, Duarte Nuno ^a   Da Mata, António Duarte Sola Pereira ^a   Patto, José Maria Vaz ^b   Barcelos, Filipe Alexandre Duarte ^b   De Almeida Rato Amaral, João Pedro ^a   De Oliveira, Miguel Constantino Mendes ^a   Ferreira, Cristina Gutierrez Castanheira ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b Portuguese Institute for Rheumatological Diseases   (Portugal)

Author keywords

Dental erosion; Gustatory stimulants; Randomized controlled trial; Saliva; Sj gren's syndrome

Indexed keywords

CITRIC ACID; FLUORIDE; MALIC ACID; UNCLASSIFIED DRUG; XEROS; XYLITOL;

ACIDITY; ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROELECTRODE; OUTCOME ASSESSMENT; PH; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SALIVATION; SAMPLE SIZE; SJOEGREN SYNDROME; TOOTH DISEASE; XEROSTOMIA;

ADULT; BUFFERS; CITRIC ACID; DOUBLE-BLIND METHOD; FEMALE; FLUORIDES; FOLLOW-UP STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; MALATES; MICROELECTRODES; MIDDLE AGED; SALIVA; SECRETORY RATE; SJOGREN'S SYNDROME; TIME FACTORS; TOOTH EROSION; XYLITOL;

EID: 80054103870     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01038.x     Document Type: Article

References (55)

1. Alves MB, Motta AC, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence Int 2004; 35: 392-6.
2. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 2004; 164: 1275-84.
3. Fox PC, Bowman SJ, Segal B, et al. Oral involvement in primary Sjogren syndrome. J Am Dent Assoc 2008; 139: 1592-601.
4. Sugai S, Takahashi H, Ohta S, et al. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjogren's syndrome: a double-blind placebo-controlled multicenter trial. Mod Rheumatol 2009; 19: 114-24.
5. Fox RI. Sjogren's syndrome. Lancet 2005; 366: 321-31.
6. Mathews SA, Kurien BT, Scofield RH. Oral manifestations of Sjogren's syndrome. J Dent Res 2008; 87: 308-18.
7. Daniels TE, Fox PC. Salivary and oral components of Sjogren's syndrome. Rheum Dis Clin North Am 1992; 18: 571-89.
8. Friedlaender MH. Ocular manifestations of Sjogren's syndrome: keratoconjunctivitis sicca. Rheum Dis Clin North Am 1992; 18: 591-608.
9. Featherstone JD. Prevention and reversal of dental caries: role of low level fluoride. Community Dent Oral Epidemiol 1999; 27: 31-40.
10. Featherstone JD. The science and practice of caries prevention. J Am Dent Assoc 2000; 131: 887-99.
11. Lussi A, Jaeggi T. Occupation and sports. Monogr Oral Sci 2006; 20: 106-11.
12. Da Mata AD, Da Silva Marques DN, Silveira JM, Marques JR, De Melo Campos Felino Et, Guilherme NF. Effects of gustatory stimulants of salivary secretion on salivary pH and flow: a randomized controlled trial. Oral Dis 2009; 15: 220-8.
13. Wu AJ. Optimizing dry mouth treatment for individuals with Sjogren's syndrome. Rheum Dis Clin North Am 2008; 34: 1001-10.
14. Featherstone JD, Lussi A. Understanding the chemistry of dental erosion. Monogr Oral Sci 2006; 20: 66-76.
15. Gambon DL, Brand HS, Nieuw AA. Acidic candies affect saliva secretion rates and oral fluid acidity. Ned Tijdschr Tandheelkd 2007; 114: 330-4.
16. Meurman JH, Frank RM. Progression and surface ultrastructure of in vitro caused erosive lesions in human and bovine enamel. Caries Res 1991; 25: 81-7.
17. Chunmuang S, Jitpukdeebodintra S, Chuenarrom C, Benjakul P. Effect of xylitol and fluoride on enamel erosion in vitro. J Oral Sci 2007; 49: 293-7.
18. Hove LH, Holme B, Young A, Tveit AB. The erosion-inhibiting effect of TiF4, SnF2, and NaF solutions on pellicle-covered enamel in vitro. Acta Odontol Scand 2007; 65: 259-64.
19. Hove LH, Young A, Tveit AB. An in vitro study on the effect of TiF(4) treatment against erosion by hydrochloric acid on pellicle-covered enamel. Caries Res 2007; 41: 80-4.
20. Hove LH, Holme B, Young A, Tveit AB. The protective effect of TiF4, SnF2 and NaF against erosion-like lesions in situ. Caries Res 2008; 42: 68-72.
21. Dogon IL, Amdur BH, Bell K. Observations on the diurnal variation of some inorganic constituents of human parotid saliva in smokers and non-smokers. Arch Oral Biol 1971; 16: 95-105.
22. Moritsuka M, Kitasako Y, Burrow MF, Ikeda M, Tagami J, Nomura S. Quantitative assessment for stimulated saliva flow rate and buffering capacity in relation to different ages. J Dent 2006; 34: 716-20.
23. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 1982; 61: 1158-62.
24. Kitasako Y, Moritsuka M, Foxton RM, Ikeda M, Tagami J, Nomura S. Simplified and quantitative saliva buffer capacity test using a hand-held pH meter. Am J Dent 2005; 18: 147-50.
25. Guyatt GH. Users' guides to the medical literature: a manual of evidence-based clinical practice. Chicago, IL: AMA Press, 2002.
26. Daniels TE. Labial salivary gland biopsy in Sjogren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27: 147-56.
27. Talal N. Sjogren's syndrome. Curr Opin Immunol 1989; 2: 622-4.
28. Young A, Amaechi BT, Dugmore C, et al. Current erosion indices - flawed or valid? Summary. Clin Oral Investig 2008; 12: S59-63.
29. Alpoz E, Guneri P, Onder G, Cankaya H, Kabasakal Y, Kose T. The efficacy of Xialine in patients with Sjogren's syndrome: a single-blind, cross-over study. Clin Oral Investig 2008; 12: 165-72.
30. Fox PC. Salivary enhancement therapies. Caries Res 2004; 38: 241-6.
31. Preetha A, Banerjee R, Huilgol N. Surface activity, lipid profiles and their implications in cervical cancer. J Cancer Res Ther 2005; 1: 180-6.
32. Samarawickrama DY. Saliva substitutes: how effective and safe are they? Oral Dis 2002; 8: 177-9.
33. Dugmore CR, Rock WP. A multifactorial analysis of factors associated with dental erosion. Br Dent J 2004; 196: 283-6.
34. Duxbury AJ. Ecstasy - dental implications. Br Dent J 1993; 175: 38.
35. Gambon DL, Van Den Keijbus PA, Van Amerongen AN. Candy sprays and -gels: effect on salivary flow and pH. Ned Tijdschr Tandheelkd 2006; 113: 27-32.
36. Giunta JL. Dental erosion resulting from chewable vitamin C tablets. J Am Dent Assoc 1983; 107: 253-6.
37. Hara AT, Zero DT. Analysis of the erosive potential of calcium-containing acidic beverages. Eur J Oral Sci 2008; 116: 60-5.
38. Rees J, Loyn T, Mcandrew R. The acidic and erosive potential of five sports drinks. Eur J Prosthodont Restor Dent 2005; 13: 186-90.
39. Gandara BK, Truelove EL. Diagnosis and management of dental erosion. J Contemp Dent Pract 1999; 15: 16-23.
40. Lussi A. Erosive tooth wear - a multifactorial condition of growing concern and increasing knowledge. Monogr Oral Sci 2006; 20: 1-8.
41. Ganss C, Schlueter N, Klimek J. Retention of KOH-soluble fluoride on enamel and dentine under erosive conditions - a comparison of in vitro and in situ results. Arch Oral Biol 2007; 52: 9-14.
42. Ganss C, Schlueter N, Hardt M, Schattenberg P, Klimek J. Effect of fluoride compounds on enamel erosion in vitro: a comparison of amine, sodium and stannous fluoride. Caries Res 2008; 42: 2-7.
43. Schlueter N, Ganss C, Mueller U, Klimek J. Effect of titanium tetrafluoride and sodium fluoride on erosion progression in enamel and dentine in vitro. Caries Res 2007; 41: 141-5.
44. Vieira A, Ruben JL, Huysmans MC. Effect of titanium tetrafluoride, amine fluoride and fluoride varnish on enamel erosion in vitro. Caries Res 2005; 39: 371-9.
45. Wiegand A, Laabs KA, Gressmann G, Roos M, Magalhaes AC, Attin T. Protection of short-time enamel erosion by different tetrafluoride compounds. Arch Oral Biol 2008; 53: 497-502.
46. Lajer C, Buchwald C, Nauntofte B, Specht L, Bardow A, Jensdottir T. Erosive potential of saliva stimulating tablets with and without fluoride in irradiated head and neck cancer patients. Radiother Oncol 2009; 93: 534-8.
47. Barbour ME, Shellis RP. An investigation using atomic force microscopy nanoindentation of dental enamel demineralization as a function of undissociated acid concentration and differential buffer capacity. Phys Med Biol 2007; 52: 899-910.
48. Gilchrist F, Santini A, Harley K, Deery C. The use of micro-Raman spectroscopy to differentiate between sound and eroded primary enamel. Int J Paediatr Dent 2007; 17: 274-80.
49. Lippert F, Parker DM, Jandt KD. In vitro demineralization/remineralization cycles at human tooth enamel surfaces investigated by AFM and nanoindentation. J Colloid Interface Sci 2004; 280: 442-8.
50. Owens BM, Kitchens M. The erosive potential of soft drinks on enamel surface substrate: an in vitro scanning electron microscopy investigation. J Contemp Dent Pract 2007; 8: 11-20.
51. Sakoolnamarka R, Burrow MF, Prawer S, Tyas MJ. Raman spectroscopic study of noncarious cervical lesions. Odontology 2005; 93: 35-40.
52. Thomas SS, Mallia RJ, Jose M, Subhash N. Investigation of in vitro dental erosion by optical techniques. Lasers Med Sci 2008; 23: 319-29.
53. Jensdottir T, Nauntofte B, Buchwald C, Bardow A. Effects of sucking acidic candy on whole-mouth saliva composition. Caries Res 2005; 39: 468-74.
54. Jensdottir T, Nauntofte B, Buchwald C, Bardow A. Effects of calcium on the erosive potential of acidic candies in saliva. Caries Res 2007; 41: 68-73.
55. Jensdottir T, Buchwald C, Nauntofte B, Hansen HS, Bardow A. Erosive potential of calcium-modified acidic candies in irradiated dry mouth patients. Oral Health Prev Dent 2010; 8: 173-8.